Skip to main content

Lurbinectedin

(LOOR-bih-NEK-teh-din)

This page contains brief information about lurbinectedin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Zepzelca
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Lurbinectedin is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that lurbinectedin provides a clinical benefit in these patients.

Lurbinectedin is also being studied in the treatment of other types of cancer.

More About Lurbinectedin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Lurbinectedin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: